FibroFind is a pre-clinical research company that uses multi-organ platforms for the development and efficacy-determination of drugs that suppress fibrosis.
A fascinating new paper describing the role of mitochondrial DNA in regulating the phenotypic features of cellular senescence which is co-authored by our CSO @derekamann1
@FibroFind are pleased to be sponsoring the very first First International Conference of Liver Pathobiology: From Bench to Bedside held in Chania, Crete which starts today!
We did it! We bought a site for a new laboratory and office building right in the heart of the great city of Newcastle! Here is an artist impression of what all be FibroFind new home from where we will put the North East of England firmly on the global biomedical sector map.
Latest research output led by our CEO @JelenaMann describing the identification of microRNA regulated pathways within the fibrotic microenvironment of human idiopathic pulmonary fibrosis ajp.amjpathol.org/article/S0…
A cool new animation describing how @FibroFind are revolutionising the search for new treatments in chronic kidney disease and paving the way for an era in which novel therapeutics are discovered using human rather than animal experimental systems. Enjoy! youtu.be/btJeMH-5uGQ
Metabolic disturbances caused by hepatitis c virus can persist after successful treatment and can be a risk for development of liver cancer. A review co-authored by Prof Derek A Mann published in Journal of Hepatology. eur03.safelinks.protection.o…
It is a privilege and an honour to be able to support youth development in the city of Newcastle and in particular with @NorthernFC who are making great strides in promoting sporting and physical fitness in girls #InternationalWomensDay
I am extremely proud as Director of @FibroFind that our company sponsors youth development at a great local sports club. @NorthernFC have a commitment to developing girls sport and physical development as this lovely picture. Congrats to the coaches 👏 #InternationalWomensDay
We at @RSMUK are delighted to be once again sponsoring the @Bionow Start Up of the Year 2021 award. Good luck to the shortlisted nominees
•@Cryoniss_Ltd
•@FibroFind
•@PandeiaT
Exciting news. We have been shortlisted in two award categories for the @Bionow annual awards - start up of the year and exporter of the year. Well done to the entire team! bionow.co.uk/news/b620152ad4…
We were proud to be presenting with @GileadSciences at the EASL International Liver Congress on a new study reporting that a combination of ACC inhibitor and FGF-19 reduces steatosis and fibrosis in our precision cut liver slice model of human NASH. #ILC2021#nash#fibrosis.
We are hiring! If you are a PhD level biologist with a strong track record in research using in vitro and/or in vivo models of disease then come and join us cv-library.co.uk/job/2140859…
We are expanding our workforce and are now recruiting a Scientific Project Manager. If you love science, enjoy leadership and want to grow your career with a young and exciting company in the healthcare field then come and join us! reed.co.uk/jobs/scientific-p…
FibroFind is expanding its workforce and have a new opening for a technical scientist. If you love science and want to work with a young vibrant company advancing the development of new medicines for the treatment of life threatening diseases then do come and join us.